Welcome : Guest

Orexo AB (Sweden) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Orexo AB, which is principally involved in Pharmaceuticals Business. Illustrated with 18 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-11114
Price: $900
Company Type: Public
Pages: 20
Date: November 2016
Market Data Tables: 18

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Orexo AB’s Sales by Product Category Worldwide (2014-2015) in Percentage for Abstral-Royalties, Abstral fixed Royalty, Milestone Payment Abstral, Edluar-Royalty, Zubsolv, and Kibion AB......3
Table 2: Orexo AB’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Sweden, UK, East Asia, US, and Other Countries......4
Respiratory Drugs......5
Table 3: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......5
Table 4: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......6
Zubsolv......7
Table 5: Zubsolv Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Generic Suboxone Tablet, Suboxone Film, and Zubsolv......7
Extended-Release Opioid......8
Table 6: Extended-Release Opioid Market by Payment Method in the US (2015) - Percentage Share Breakdown by Value for Cash, Commercial, Managed Medicaid, Medicaid and Medicare......8
Narcolepsy......9
Table 7: Diagnosed Narcolepsy Patients Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Current Xyrem Patient, Untreated Diagnosed Patients and WF Peak Additional Xyrem Patients......9
Narcotic Drugs......10
Table 8: Narcotic Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value Sales for Butorphanol, Daphine Giraldii Nitsche, Dihydrocodeine/Paracetamol and dihydrocodeine, Fentanyl, Morphine, Oxycodone Acetaminophen, Tramadol, and Others......10
Table 9: Narcotic Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Morphine, Oxycodone, Tramadol and Others......11
Respiratory Therapeutics......12
Table 10: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......12
Narcotic Drugs......13
Table 11: Market Shares of Leading Narcotic Drugs Manufacturers by Value Sales in China (2014) - Percentage Breakdown for Beijing Mundipharma Ltd., China National Medicines Corporation, Impofstoffwerk Dessau Tomau GmbH, Notheast Pharmaceutical Group ., Ltd., Shanhaiguan Pharmaceutical Co., Ltd., Southwest Pharmaceutical Co., Ltd., The Grunenthal Group, Weihal Lotus Pharmaceutical Co., Ltd., Wuhan HumanWell Bi-Tech Industry Co., Ltd., Xian-Janseen Pharmaceutical Ltd., and Others......13
Sleep Aid Drugs......14
Table 12: Market Shares of Leading Sleep Disorders Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Sanofi S.A., and Others......14
Table 13: Sleep Aid Drugs Market by Product Type in the US (2015) - Percentage Share Breakdown by Prescriptions for Lunesta Generic Ambien(Sanofi), and Lunesta Generic(Sunovion)......15
Sleep Apnea......16
Table 14: Market Shares of Leading Sleep Apena Product Providers in the US (2015) - Percentage Breakdown by Value for Koninklijke Philips N.V., ResMed, Inc., and Others......16
Table 15: Market Shares of Leading Sleep Apnea Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for CareFusion Corporation, Respironics, Inc., and Others......17
Insomnia Drugs......18
Table 16: Market Shares of Leading Insomnia Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Jazz Pharmaceuticals (JAZZ), Sanofi S.A. (SNY), Somaxon Pharmaceuticals, Inc. (SOMX), Takeda Pharmaceutical Company Limited, Generics, and Others......18
Opioids......19
Table 17: Market Shares of Leading Opioids Brands Worldwide (2015) - Percentage Share Breakdown by Value for Codeine, Hydrocodone, Oxycodone and Others......19
Table 18: Orexo AB’s Sales by Product Segment Worldwide (2013-2014) in SK Millions for Abstral Royalties, Abstral Fixed Royalty, Milestone Payment Abstral, Edluar Royalties, Zubsolv, Kibion, Partner-Financed R&D Costs, Licensing Revenue for Development Projects and Others......20